Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02255097 |
|---|---|
| Brief Title: | Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055) |
| First Submitted : | September 30, 2014 |
| First Submitted that Met QC Criteria : | September 30, 2014 |
| First Posted : | October 2, 2014 (Estimate) |
| Results First Submitted : | April 20, 2017 |
| Results First Submitted that Met QC Criteria : | June 7, 2017 |
| Results First Posted : | July 6, 2017 |
| Last Update Submitted that Met QC Criteria : | June 23, 2022 |
| Last Update Posted : | June 28, 2022 |